Countries race to address swine flu pandemic
This article was originally published in SRA
Executive Summary
Drug regulatory authorities around the world are working with pharmaceutical companies to develop and approve a vaccine for the influenza A/H1N1 pandemic (swine flu) virus that has so far affected 134,503 people and caused 816 deaths1. The swine flu outbreak started in April in Mexico2 and was officially declared a pandemic by the World Health Organization in June3.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.
EMA To Get The Ball Rolling On Making CTIS Global
The European Medicines Agency wants to further improve the visibility of data in the Clinical Trials Information System by establishing it as a World Health Organization primary registry.